Sarah Linnstaedt and collaborators publish a review article “Literature review and methodological considerations for understanding circulating risk biomarkers following trauma exposure” in Molecular Psychiatry (PMID: 31863020).

The Linnstaedt Lab was awarded an R01 grant from the NINDS to study mechanisms, safety and efficacy of FKBP51 antagonism to prevent chronic pain.

Dr. Sarah Linnstaedt received a 2020 Award in Pain grant from The Rita Allen Foundation, which provides a $150,000 three year grant to fund innovative research on critical topics related to the biological mechanisms of pain.

Linnstaedt Lab members publish their article “MicroRNA-19b predicts widespread pain and posttraumatic stress symptom risk in a sex-dependent manner following trauma exposure” in PAIN (PMID: 31569141).